Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ultragenyx Pharmaceutical Company Profile (NASDAQ:RARE)

Consensus Ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $77.50 (10.92% downside)

Analysts' Ratings History for Ultragenyx Pharmaceutical (NASDAQ:RARE)
Show:
DateFirmActionRatingPrice TargetActions
5/23/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$74.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Canaccord GenuityReiterated RatingBuy$68.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Jefferies GroupReiterated RatingBuy$74.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Canaccord GenuityBoost Price TargetBuy$68.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015WedbushInitiated CoverageOutperform$74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Canaccord GenuityReiterated RatingBuy$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015CRT CapitalInitiated CoverageBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Canaccord GenuityBoost Price TargetBuy$62.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Canaccord GenuitySet Price TargetBuy$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Canaccord GenuityInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Robert W. BairdInitiated CoverageOutperform$64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Morgan StanleyInitiated CoverageOverweight$81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Canaccord GenuityInitiated CoverageBuy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014JPMorgan Chase & Co.Initiated CoverageOverweight$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2013 forward)